NASH Model Service

The NASH model (Non-Alcoholic Steatohepatitis model) has become a critical tool in the study of liver diseases, particularly for researchers focusing on the development of treatments for NASH and related conditions. By simulating the progression of Non-Alcoholic Fatty Liver Disease (NAFLD) into NASH, this model allows pharmaceutical companies and research institutions to better understand the underlying mechanisms of liver inflammation and fibrosis. Researchers use the NASH model to assess the effectiveness of various drug candidates, offering valuable insights into their potential to prevent or reverse liver damage. With the increasing prevalence of NASH globally, the NASH model has emerged as an essential part of clinical trials and drug discovery pipelines.